Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone in Severe Head Injury
NCT06631547Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Dec 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of progesterone in traumatic brain injury (TBI) (2 arms), sponsored by Assiut University. Primary endpoints: Glasgow Outcome Scale Extended at 1 year and Functional Independence Measure at 1 year. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
progesterone
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06631547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06631547.